🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is designed to evaluate the safety and efficacy of pomalidomide ...
Status
Active Not Recruiting
Location
Royal Melbourne Hospital
Start Date
2025-05-13
Trial ID
NCT06660498
Treatments Being Tested
This study aims at establishing a new powerful combination of daratumumab a...
Status
Terminated
Location
Policlinico Universitario "Mater Domini"
Start Date
2021-06-23
Trial ID
NCT04895917
Treatments Being Tested
Background: \- Pomalidomide is a drug that can treat cancer through severa...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2012-01-10
Trial ID
NCT01495598
Treatments Being Tested
This study is designed as a phase I-II, open label, dose finding study. St...
Status
Unknown
Location
Duke University Medical Center
Start Date
2013-01-07
Trial ID
NCT01754402
Treatments Being Tested
The purpose of this study is to determine the pharmacokinetics (PK) and saf...
Status
Completed
Location
Colorado Blood Cancer Institute
Start Date
2012-06-01
Trial ID
NCT01575925
Treatments Being Tested
This study is for research purposes only and will not treat any disease or ...
Status
Completed
Location
Orlando Clinical Research Center
Start Date
2013-03-01
Trial ID
NCT01835561
Treatments Being Tested
This is a prospective, single-center, open-label phase Ib study aimed at de...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-07-01
Trial ID
NCT04355039
Selinexor (KPT-330, Xpovio) is a first in class selective inhibitor of nucl...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2021-11-18
Trial ID
NCT04925193
Treatments Being Tested
This is a prospective, single-center study exploratory clinical trial, aim ...
Status
Recruiting
Location
National Clinical Research Center for Kidney Diseases, Jinling Hospital
Start Date
2023-01-01
Trial ID
NCT06376214
Because the activity of CC-4047 addresses numerous mechanisms of carcinoma ...
Status
Completed
Location
University of Colorado Cancer Center
Start Date
2007-11
Trial ID
NCT00540579
Treatments Being Tested